Caffeinated Chewing Gum on 400-meter Performance

NCT06430996 | Completed DMC

• 1 other identifier: 113-2
• Study Type: interventional
• Target: 19
• Locations: 1 country
• Sites: 1

Brief Summary

20 trained sprinter were divided into caffeine Gum trial (CAF) and Placebo trial (PL) with a randomized, double-blind study design. The participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) or Placebo Gum (PL) for 10 minutes. The outcomes are Running-Based Anaerobic Sprint Test and 400-meter sprint test was performed.

Conditions

Caffeine; Placebo

Keywords

exercise performance; fatigue index; α amylase

Outcome Measures

Primary Outcomes (2)

• Running-Based Anaerobic Sprint Test (RAST)

  Measure the fatigue index (%)

  15 minutes after intervention

• 400-meter sprinting

  Measure the 400-meter completion time (seconds)

  30 minutes after RAST

Study Arms (2)

caffeine gum

EXPERIMENTAL

The participants chewing caffeine gum 10 minutes before exercise

Dietary Supplement: caffeine

placebo gum

PLACEBO COMPARATOR

The participants chewing placebo gum 10 minutes before exercise

Dietary Supplement: caffeine

Interventions

caffeine DIETARY_SUPPLEMENT

The participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) or Placebo Gum (PL) for 10 minutes. After rested for 15 minutes, the participants underwent tests.

Also known as: plocabo gum

caffeine gum; placebo gum

Eligibility Criteria

• Age: 20 Years - 30 Years
• Sex: male
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• years of professional short sprinting training
• months of ongoing training, and
• months of recovery from sports injuries such as strains and sprains.

You may not qualify if:

• Non-specialized sprinters.
• has not trained regularly for the past 6 months.
• has recovered from an athletic injury.
• less than 3 months of recovery from a sports injury, or participants with epilepsy, hypertension, hyperlipidemia, heart disease, arthritis, osteoporosis, brain injury, or a history of caffeine allergy.

Sponsors & Collaborators

• Chih-Hui Chiu: lead
• National Science and Technology Council: collaborator

Study Sites (1)

National Taiwan University of Sport

Taichung, 404, Taiwan

Location

MeSH Terms

Interventions

Caffeine

Intervention Hierarchy (Ancestors)

Xanthines; Alkaloids; Heterocyclic Compounds; Purinones; Purines; Heterocyclic Compounds, 2-Ring; Heterocyclic Compounds, Fused-Ring

Study Officials

• ChihHui Chiu, PhD

  Sport Science Research Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: INVESTIGATOR
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: April 8, 2024
• First Posted: May 28, 2024
• Study Start: April 8, 2024
• Primary Completion: July 1, 2024
• Study Completion: July 1, 2024
• Last Updated: August 6, 2024

Record last verified: 2024-08

Data Sharing

• IPD Sharing: Will not share

Locations

TW (1)